ImmunityBio, Inc 10-K for FY2023
ImmunityBio, Inc. (IBRX)
10-K
2024-03-19
For: 2023-12-31
View Original
Added on
April 10, 2026
About this 10-K
ImmunityBio, Inc filed this 10-K on March 19, 2024, covering the fiscal year ended December 31, 2023 (FY2023).
Headline figures
Fiscal year ended December 31, 2023, as reported in this filing, compared with the same period a year earlier where the filing states it.
- Revenue
- $622K
- up 159.2% from $240K a year earlier
- Net loss
- $583.2M
- compared with a net loss of $416.57M a year earlier
- Diluted EPS
- -$1.15
- compared with -$1.04 a year earlier